Jazz Pharmaceuticals plc
Nasdaq: JAZZPharmaceutical Preparations · Entity-resolved by Clous
CIK0001232524
TickerJAZZ
ExchangeNasdaq
SIC2834
StateL2
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2025-12-31
$4.27B
+4.9% YoY
Net IncomeFY2025-12-31
-$356.15M
-163.6% YoY
Total AssetsFY2025-12-31
$11.66B
-2.9% YoY
EquityFY2025-12-31
$4.32B
+5.5% YoY
Shares OutstandingFY2025-12-31
62.74M
—
Operating Cash FlowFY2025-12-31
$1.36B
-2.9% YoY
Short interest & fails
Cost to borrow0.28%1M shares availablegeneral collateral
Short-sale volume
FINRA Reg SHO · daily68.2%
short of total volume · 2026-06-18
2026-06-1868.2%
2026-06-1765.5%
2026-06-1650.6%
2026-06-1549.7%
2026-06-1271.2%
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $3.66B | $3.83B | $4.07B | $4.27B | +4.9% | 100% |
| Net Income | -$224.06M | $414.83M | $560.12M | -$356.15M | -163.6% | -8% |
| Total Assets | $10.84B | $11.39B | $12.01B | $11.66B | -2.9% | 273% |
| Equity | $3.09B | $3.74B | $4.09B | $4.32B | +5.5% | 101% |
| Operating Cash Flow | $1.27B | $1.09B | $1.4B | $1.36B | -2.9% | 32% |
| Shares Outstanding | — | — | — | 62.74M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001232524